Gyrodyne , LLC (NASDAQ:GYRO – Get Free Report) was the recipient of a significant increase in short interest in the month of August. As of August 14th, there was short interest totaling 1,295 shares, an increase of 257.7% from the July 30th total of 362 shares. Based on an average trading volume of 1,475 shares, the short-interest ratio is presently 0.9 days. Approximately 0.1% of the company’s shares are short sold.
Gyrodyne Stock Performance
Gyrodyne stock opened at $5.28 on Thursday. The stock’s 50-day moving average is $5.76 and its 200-day moving average is $7.07. Gyrodyne has a 12 month low of $5.28 and a 12 month high of $11.00.
Institutional Inflows and Outflows
An institutional investor recently bought a new stake in Gyrodyne stock. Susquehanna International Group LLP bought a new stake in shares of Gyrodyne , LLC (NASDAQ:GYRO – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 14,186 shares of the real estate investment trust’s stock, valued at approximately $142,000. Susquehanna International Group LLP owned approximately 0.65% of Gyrodyne at the end of the most recent quarter. Institutional investors and hedge funds own 71.36% of the company’s stock.
About Gyrodyne
Gyrodyne Company of America, Inc is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.
The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island.
Featured Stories
- Five stocks we like better than Gyrodyne
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Gyrodyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyrodyne and related companies with MarketBeat.com's FREE daily email newsletter.
